We are live on ! Find out more
EP

Elkfork Partners Portfolio holdings

AUM $4.11B
1-Year Est. Return 5.26%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
+5.26%
3 Year Est. Return
+52.4%
5 Year Est. Return
10 Year Est. Return
AUM
$4.21B
AUM Growth
+$323M
Cap. Flow
+$69.3M
Cap. Flow %
1.65%
Top 10 Hldgs %
23.38%
Holding
1,044
New
39
Increased
664
Reduced
239
Closed
30

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$14.9M
2
XOM icon
ExxonMobil
XOM
+$13.7M
3
TDOC icon
Teladoc Health
TDOC
+$13.4M
4
MET icon
MetLife
MET
+$13.3M
5
KNX icon
Knight Transportation
KNX
+$12.7M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$21.3M
2
CAT icon
Caterpillar
CAT
+$18.6M
3
SLB icon
SLB Ltd
SLB
+$16.1M
4
CA
CA, Inc.
CA
+$14.9M
5
MSM icon
MSC Industrial Direct
MSM
+$14.4M

Sector Composition

Rank Sector Weight
1 Technology 18.23%
2 Financials 15.62%
3 Healthcare 14.25%
4 Consumer Discretionary 13.19%
5 Industrials 10.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFPT
451
DELISTED
Proofpoint, Inc.
PFPT
$777K 0.02%
7,310
+238
+3% +$27.7K
TREX icon
452
Trex
TREX
$4.66B
$775K 0.02%
20,128
+4,148
+26% +$160K
NEOG icon
453
Neogen
NEOG
$2.72B
$771K 0.02%
21,556
+5,780
+37% +$246K
WTFC icon
454
Wintrust Financial
WTFC
$10.9B
$771K 0.02%
9,072
+2,520
+38% +$224K
FMS icon
455
Fresenius Medical Care
FMS
$14.1B
$769K 0.02%
14,960
AZN icon
456
AstraZeneca
AZN
$243B
$766K 0.02%
9,673
LIVN icon
457
LivaNova
LIVN
$4.48B
$766K 0.02%
6,182
+1,540
+33% +$182K
CMS icon
458
CMS Energy
CMS
$22.7B
$761K 0.02%
15,540
-588
-4% -$28.7K
PRLB icon
459
Protolabs
PRLB
$1.88B
$759K 0.02%
4,692
+850
+22% +$120K
ASH icon
460
Ashland
ASH
$3.35B
$755K 0.02%
+9,010
New +$752K
FLS icon
461
Flowserve
FLS
$9.79B
$750K 0.02%
13,702
-2,788
-17% -$135K
CHRW icon
462
C.H. Robinson
CHRW
$17.1B
$746K 0.02%
7,616
-448
-6% -$42K
BKR icon
463
Baker Hughes
BKR
$59.3B
$745K 0.02%
22,022
-176
-0.8% -$5.82K
SWX icon
464
Southwest Gas
SWX
$6.55B
$744K 0.02%
9,418
+2,006
+27% +$159K
SR icon
465
Spire
SR
$4.81B
$743K 0.02%
10,098
+1,700
+20% +$126K
ESPR
466
DELISTED
Esperion Therapeutics
ESPR
$739K 0.02%
16,660
+14,450
+654% +$663K
FLR icon
467
Fluor
FLR
$7.05B
$731K 0.02%
12,580
-6,902
-35% -$376K
NUE icon
468
Nucor
NUE
$57.5B
$728K 0.02%
11,480
+448
+4% +$28.7K
CBRL icon
469
Cracker Barrel
CBRL
$1.31B
$721K 0.02%
4,900
+1,316
+37% +$197K
HR
470
DELISTED
Healthcare Realty Trust Incorporated
HR
$717K 0.02%
24,500
+7,336
+43% +$219K
CIEN icon
471
Ciena
CIEN
$52.4B
$716K 0.02%
22,932
+5,908
+35% +$166K
IHY icon
472
VanEck International High Yield Bond ETF
IHY
$43.1M
$716K 0.02%
29,400
UBS icon
473
UBS Group
UBS
$173B
$716K 0.02%
45,390
+4,488
+11% +$70.6K
DVN icon
474
Devon Energy
DVN
$51.1B
$712K 0.02%
17,820
+1,144
+7% +$48.7K
DLR icon
475
Digital Realty Trust
DLR
$70B
$710K 0.02%
6,314
-264
-4% -$31.6K

Similar funds

Elkfork Partners's Q3 2018 Portfolio in Review

As of Q3 2018, Elkfork Partners held 1,044 positions worth $4.21B, up 8.3% from $3.88B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Elkfork Partners's Q3 2018 filing shows 39 new, 664 increased, 239 reduced and 30 closed positions. Its largest new stake was VICI Properties: 120,876 shares worth $2.61M. The largest sale was Gilead Sciences, an estimated $21.3M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Elkfork Partners's largest Q3 2018 buy was VICI Properties: 120,876 shares worth $2.61M.
  • Elkfork Partners added most to Salesforce in Q3 2018, an estimated $14.9M increase.
  • Elkfork Partners's biggest Q3 2018 reduction was Gilead Sciences, cutting an estimated $21.3M.
  • Elkfork Partners fully exited Energen in Q3 2018, selling an estimated $3.57M.
  • Elkfork Partners's ten largest holdings make up 23% of its $4.21B portfolio in Q3 2018.
  • Elkfork Partners opened 39 new positions and closed 30 in Q3 2018.
  • Elkfork Partners's portfolio value rose 8.3% quarter-over-quarter to $4.21B.

Based on Elkfork Partners's 13F filing for Q3 2018, filed 14 Nov 2018.